Skip to main content
OceansBio Co., Ltd. logo

OceansBio Co., Ltd. — Investor Relations & Filings

Ticker · 332190 ISIN · KR7332190008 KO Manufacturing
Filings indexed 35 across all filing types
Latest filing 2026-04-29 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 332190

About OceansBio Co., Ltd.

https://oceansbio.com/

OceansBio Co., Ltd. is a medical technology company that develops and manufactures electroceuticals, or electronic medicines, to treat neurological diseases. The company's core technology is vagus nerve stimulation (VNS), which it applies through both wearable (extracorporeal) and implantable devices. Its flagship product, TaVNS, is a wearable electrical stimulation device designed for patients with conditions such as epilepsy and depression. OceansBio integrates artificial intelligence (AI) into its medical devices to provide personalized treatment solutions.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a Korean ‘주요사항보고서(유상증자결정)’ (Major Event Report – Paid‐in Capital Increase Decision) and specifically details a share issuance via third‐party allocation (유상증자) and corrections thereto. This is an announcement of a new share issue and capital change. According to the filing definitions, announcements regarding new share issues and other capital changes fall under Share Issue/Capital Change (Code: SHA).
2026-04-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 92% confidence The document is a Korean ‘주식등의 대량보유상황보고서(약식)’ (“Report on Large Holdings of Shares (simplified)”) filed by Capstone Partners Co., Ltd. under the Capital Markets Act, detailing the number of shares held, percentage ownership, acquisition method and reasons. This aligns exactly with a Major Shareholding Notification (notification of changes in significant share ownership levels). Thus, it should be classified as MRQ.
2026-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 95% confidence The document is a Korean “임원·주요주주 특정증권등 소유상황보고서” (Report on Ownership of Specific Securities by Executives and Major Shareholders). It records a share acquisition that brings the reporter’s holding above 10%, i.e., a change in significant share ownership. This matches the definition of a Major Shareholding Notification (code MRQ).
2026-04-01 Korean
증권발행결과(자율공시) (제3자배정 유상증자_상환전환우선주)
Share Issue/Capital Change Classification · 92% confidence The document is a voluntary disclosure (“자율공시”) detailing the issuance results of redeemable convertible preferred shares via a third‐party allocation, including the number of shares, amounts, and dates. This is a direct announcement of a new share issue/capital change, matching the definition for “Share Issue/Capital Change” (SHA).
2026-03-31 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 92% confidence The document is a voluntary disclosure of the results of a securities issuance (redeemable convertible preferred shares) including number of shares, amount, payment date, and related board resolution dates. This is a clear announcement of a new share issue (capital change) rather than a full report or presentation. Therefore it fits the ‘Share Issue/Capital Change’ category.
2026-03-27 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 96% confidence The document is a Korean ‘주요사항보고서(유상증자결정)’ – a Major Matters Report announcing and correcting details of a paid‐in capital increase (유상증자) decision, including issuance price, base price discount, allotment method, third‐party allotment, and timing. It is a regulatory filing under the Capital Markets Act concerning a share issue/capital change, which aligns with our ‘Share Issue/Capital Change’ category (SHA).
2026-03-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.